Your search history is turned on.
Date: April 29, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Veronique Laberge, Chief Financial Officer of NuGen Medical Devices Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and informat...
Date: April 29, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, LABERGE, Veronique, an officer of the reporting issuer noted below have examined this Form 13- 502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reaso...
Microsoft Word - NuGen FS 2023-12-31_FINAL NuGen Medical Devices Inc. Consolidated Financial Statements December 31, 2023 and 2022 (expressed in Canadian dollars) KPMG LLP, an Ontario limited liability partnership and member firm of the KPMG global organization o...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
Microsoft Word - Form 52-109FV1 - CEO FORM 52-109FV1 CERTIFICATION OF ANNUAL FILINGS VENTURE ISSUER BASIC CERTIFICATE I, Ian Heynen, Chief Executive Officer of NuGen Medical Devices Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and infor...
Microsoft Word - NuGen - MDA - 2023-12-31_FINAL Page 1 of 17 Managements Discussion and Analysis For the years ended December 31, 2023 and 2022 Page 2 of 17 This Managements Discussion and Analysis (MD&A) of financial results is dated April 29, 2024 and revie...
Date: April 15, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
NuGen Announces Debt Settlement and Amendments to Care4Pharma Share Purchase Agreement April 15th, 2024 Toronto, Ontario NuGen Medical Devices Inc. (TSXV: NGMD) (the Company or "NuGen") announces that it has agreed to settle an aggregate of 275,000 of indebtedness owed to Care4Pharma B.V. (Care4Pharma), an arm...
Date: January 30, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
NuGen Announces Completion of Product Training with Sol Millennium as European Markets Expand January 30th, 2023 Toronto, Ontario NuGen Medical Devices Inc. (TSXV: NGMD) (the Company or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as o...
Date: January 19, 2024 Jurisdictions: Alberta, British Columbia, Ontario, Saskatchewan
NuGen Receives Two Additional Sales Orders for InsuJet and Expands Distribution into Argentina, Chile, Costa Rica and Peru January 19th, 2024 Toronto, Ontario NuGen Medical Devices Inc. (TSXV: NGMD) (the Company or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to report th...